Navigation Links
NineSigma Declares "Innovate or Die" Is the Mantra for Business Success
Date:7/20/2011

paramount to its innovation efforts. The greeting card leader partnered with NineSigma to develop a new line of technology enabled cards for its next generation of consumers.

"Scanning the globe to find new innovation solutions requires a costly use of time and resources," said Tom Esselman, Innovation Exploration Leader at Hallmark. "NineSigma accelerated the product development process and helped us bring more unique items to market. That helped us to win at the retail level - these activities contributed to our best year ever since 2007."

Key to the success of the Hallmark innovation was the ability to tap the world's largest open global network of solution providers spanning all industries and technical disciplines. In addition to this, NineSigma provides a unique blend of market and technology intelligence, accelerated product development, leadership development and Open Innovation training and consulting.

"Leaders like Hallmark, AkzoNobel and our other clients won't allow themselves to be eclipsed by competitors who strive to bring products and new technologies to market faster," cautions NineSigma CEO Andy Zynga. "We provide the end to end solutions that support our clients' growth targets, enabling them to achieve measurable results in a reduced amount of time. They know it's not hyperbole to say in today's competitive marketplace the mantra for business success is to innovate or die."  

Ready to Innovate?

While the need to innovate is clear, how to go about it in the current environment of Open Innovation is not always so obvious or simple. It's not enough to just reach out to innovators globally to access new capabilities and knowledge. In addition, organizations should strive to maximize collaboration internally and within their existing networks of universities, suppliers and other research partners.

NineSigma has developed a free, interactive rea
'/>"/>

SOURCE NineSigma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Afghanistan declares its first national park
2. M.D.C. Holdings Declares Quarterly Cash Dividend
3. SAFRAN to Acquire Motorolas Biometrics Business
4. Entrepreneurs wanted for NJIT workshops about how to launch a business
5. David Rose to present Howe School lecture on new technologies and business models, Jan. 29
6. A sticky business -- how cancer cells become more gloopy as they die
7. Recession Puts Focus on Business Optimisation and Excellence to Strengthen Business Core
8. In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter
9. Business, scientific, higher education groups laud President Obamas commitment to science
10. Platforms in space to help businesses
11. No comfort in comfort foods during tough economic times, says Moore School of Business study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... , July 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... the growing mobile commerce market announces a revised version of one ... The commercial will air on CNBC in New York ... and San Francisco metro areas. ... focuses on Wocket,s ability to replace all the cards in your ...
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... cell research ?including research involving human embryonic stem cells ... to a position statement adopted by the Board of ... "As the community of scientists on the front lines ... our belief that continued experimentation with human stem cells ...
... one bacterial cell can stop the growth of another on ... a dormant state, rather than dying. The findings have implications ... , The discovery by a team of scientists working in ... University of California, Santa Barbara, is reported in the August ...
... and physiologically remarkable structures such as the vertebrate ... and theorizing by biologists. In work reported this ... a critical eye protein has revealed a previously ... and those of the more primitive light-sensing systems ...
Cached Biology News:AACR Favors 'full spectrum of stem cell research biology' 2AACR Favors 'full spectrum of stem cell research biology' 3One bacteria stops another on contact 2Insight into our sight: A new view on the evolution of the eye lens 2
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
(Date:7/29/2015)... , July 30, 2015 ... reports results for the second quarter of 2015. ... group,s results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics ... Q2 results - Performance drivers ...
(Date:7/29/2015)... Inc. (NYSE: BIOA ) today announced that ... resigned.  The Company has hired Andrew Ashworth , ... 2014, as full time interim CFO and has launched ... Andy Ashworth began his employment today, to overlap ... was the Company,s CFO from September 2011 to December ...
(Date:7/29/2015)... ... July 29, 2015 , ... Brady (NYSE:BRC), a global leader ... . To align chemical container labeling with OSHA’s updated Hazard Communication (HazCom) Standard ... an example of an accurate label, and pictogram uses and meanings. , “With ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2
... --, SAN DIEGO, CA, Oct. 18 /PRNewswire-FirstCall/ ... Company,has completed enrollment of the first cohort in ... and tolerability of new HspE7 in patients with,cervical ... to dose up to 5 cohorts comprising twenty-four,patients. ...
... 18 Sigma-Aldrich (Nasdaq:,SIAL) announced today the ... System. N-TER allows researchers to reproducibly,interrogate gene ... types that,have previously not been considered amenable ... lipid-based siRNA transfection reagents exhibit a number,of ...
... today published analyses of its second-generation map of ... markers than the initial version unveiled in 2005. ... consortium describes how the higher resolution map offers ... common diseases, explore the structure of human genetic ...
Cached Biology Technology:Nventa updates progress of cervical dysplasia trial with new HspE7 2Nventa updates progress of cervical dysplasia trial with new HspE7 3Nventa updates progress of cervical dysplasia trial with new HspE7 4Nventa updates progress of cervical dysplasia trial with new HspE7 5Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types 2Consortium publishes Phase II map of human genetic variation 2Consortium publishes Phase II map of human genetic variation 3Consortium publishes Phase II map of human genetic variation 4Consortium publishes Phase II map of human genetic variation 5Consortium publishes Phase II map of human genetic variation 6
...
Jak3 Antibody Ship: Hot Store: -20 C...
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Applications: Western blotting Stability: Room temperature, indefinitely ...
Biology Products: